Biotransformation of Timosaponin BII into Seven Characteristic Metabolites by the Gut Microbiota

Timosaponin BII is one of the most abundant Anemarrhena saponins and is in a phase II clinical trial for the treatment of dementia. However, the pharmacological activity of timosaponin BII does not match its low bioavailability. In this study, we aimed to determine the effects of gut microbiota on t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Molecules
Asıl Yazarlar: Dong, Guo-Ming, Yu, Hang, Pan, Li-Bin, Ma, Shu-Rong, Xu, Hui, Zhang, Zheng-Wei, Han, Pei, Fu, Jie, Yang, Xin-Yu, Keranmu, Adili, Niu, Hai-Tao, Jiang, Jian-Dong, Wang, Yan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8270264/
https://ncbi.nlm.nih.gov/pubmed/34202717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules26133861
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller